- 专利标题: Therapeutic agent for nervous system disease
-
申请号: US17748553申请日: 2022-05-19
-
公开(公告)号: US11679122B2公开(公告)日: 2023-06-20
- 发明人: Hiroyuki Tanaka , Hideki Yoshikawa , Hideki Mochizuki , Tsuyoshi Murase , Tsutomu Sasaki , Kousuke Baba , Toru Iwahashi , Mitsuru Naiki
- 申请人: OSAKA UNIVERSITY , NIPPON ZOKI PHARMACEUTICAL CO., LTD.
- 申请人地址: JP Suita
- 专利权人: OSAKA UNIVERSITY,NIPPON ZOKI PHARMACEUTICAL CO., LTD.
- 当前专利权人: OSAKA UNIVERSITY,NIPPON ZOKI PHARMACEUTICAL CO., LTD.
- 当前专利权人地址: JP Suita; JP Osaka
- 代理机构: Oliff PLC
- 优先权: JP 2017245133 2017.12.21 JP 2018156503 2018.08.23
- 分案原申请号: US16907913 2020.06.22
- 主分类号: A61K31/714
- IPC分类号: A61K31/714 ; A61P25/28 ; A61K9/00
摘要:
An object is to provide a drug which is useful in treating a nervous system disease. A drug containing vitamin B12 as an active ingredient according to the present invention has an M2 macrophage/microglia induction promoting effect, an M1 macrophage/microglia induction inhibiting effect, a nerve regeneration promoting effect, and the like and is very useful as a therapeutic agent for a nervous system disease, and particularly useful as a therapeutic agent for a central nervous system disease such as cerebral infarction, dementia, or spinal cord injury.
公开/授权文献
- US20220273692A1 THERAPEUTIC AGENT FOR NERVOUS SYSTEM DISEASE 公开/授权日:2022-09-01
信息查询